|
UK Body Rejects Novartis Asthma Drug Xolair In Kids Under 12
Wall Street Journal … on the publicly-funded National Health Service of Novartis AG's (NVS) asthma drug Xolair for treating severely asthmatic children under the age of 12, … |
View full post on asthma – Google News